FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Solid Tumor, Adult
Interventions: DRUG: FT538|DRUG: Cyclophosphamide|DRUG: Fludarabine|COMBINATION_PRODUCT: Monoclonal antibody - Dose Escalation|COMBINATION_PRODUCT: Monoclonal antibody - Dose Expansion
Sponsor: Fate Therapeutics